Study Identifies Profile of Blood-Based Inflammatory Proteins as Potential FTD Biomarker
A study published in the journal Brain earlier this year identified a profile of inflammation-related proteins that could potentially serve as a FTD biomarker gauging the severity of the disease.…
Read MoreTips & Advice – Navigating FTD-ALS
In 2011, researchers discovered that variants of the C9orf72 gene are the most common cause of both genetic FTD and amyotrophic lateral sclerosis (ALS). Nevertheless, it is important to recognize…
Read MoreCoya Therapeutics Reports Positive Interim Results in Clinical Trial for Experimental FTD Therapy
Coya Therapeutics announced positive interim results for its clinical trial for a potentially disease-modifying treatment course for FTD, citing data showing that it helped to prevent cognitive decline. Therapeutics Address…
Read MoreIn-Person AFTD Meet & Greet in Astoria, New York
Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event in Astoria, NY, hosted by AFTD Ambassador Jackie Shapiro, on September 6,…
Read More2025 Honolulu Marathon
The AFTD-Team is an Official Charity Partner of the 2025 Honolulu Marathon taking place on December 14, 2025! We have 10 guaranteed entries and 10 runners who want those entries, but they need to…
Read More2025 BMW Dallas Marathon
Join select AFTD staff and members of the local community as we bring greater FTD awareness to the surrounding Dallas area and raise funds to help people affected by FTD.…
Read More
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)